Skip to Main Content

Paper Details

Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease.
Gut
40
2022
NAFLD, Non-Alcoholic Fatty Liver Disease, diabetes, fibrosis, gamma-glutamyl transferase, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, patients, platelet
Author NameAffiliation
Rohit LoombaNAFLD Research Center, University of California San Diego
Rohit Loomba
Mark A ValasekUniversity of California San Diego
Rohit LoombaNAFLD Research Center, University of California San Diego
Rohit LoombaUniversity of California San Diego
  • 1 - 5

Datasets

Release 1.2